Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
Go back to Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026| (NASDAQ: ROIV) | Delayed: 31.58 +0.15 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.43 | 52 Week High | $ | |||
| Open | $31.64 | 52 Week Low | $ | |||
| Day High | $31.99 | P/E | N/A | |||
| Day Low | $31.39 | EPS | $ | |||
| Volume | 1,008,351 | |||||

